TY  - GEN
AU  - Patti,F
AU  - Amato,M P
AU  - Bastianello,S
AU  - Caniatti,L
AU  - Di Monte,E
AU  - Ferrazza,P
AU  - Goretti,B
AU  - Gallo,P
AU  - Morra,V Brescia
AU  - Lo Fermo,S
AU  - Picconi,O
AU  - Tola,M R
AU  - Trojano,M
TI  - Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis
SN  - 1477-0970
PY  - 2010///0308
KW  - Adolescent
KW  - Adult
KW  - Cognition Disorders
KW  - drug therapy
KW  - Cohort Studies
KW  - Disability Evaluation
KW  - Disease Progression
KW  - Dose-Response Relationship, Drug
KW  - Endpoint Determination
KW  - Female
KW  - Humans
KW  - Immunologic Factors
KW  - therapeutic use
KW  - Injections, Subcutaneous
KW  - Interferon beta-1a
KW  - Interferon-beta
KW  - administration & dosage
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - complications
KW  - Neuropsychological Tests
KW  - Prospective Studies
KW  - Survival Analysis
KW  - Young Adult
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1177/1352458509350309
ER  -